XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
ASEAN Investment Challenge (AIC) 2024 brings together more than 5,000 higher education students for an insightful journey into responsible investing
- The company reports KRW373.0 billion in net sales,KRW166.3 billion in operating profit,and KRW142.4 billion in net income,reflecting year-over-year increases of 16.7%,41.2%,and 45.8%,respectively
CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi
Milestone reaffirms Hyundai Motor Group\'s commitment to safety,quality,design,and performance More than 5,000 vehicles have been tested and driven more than 20-million miles at the facility since ope
NEW YORK,Feb. 13,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,t
HAIKOU,China,Feb. 13,2025-- A report from Hainan International Media Center: On Feb. 12,the date of the 2025 Lantern Festival,highly anticipated fireworks and drone shows were held in Haikou,creating
KANSAS CITY,Mo.,Feb. 13,2025-- Lockton,the world\'s largest independent insurance brokerage,is pleased to announce the establishment of a Digital Office to drive innovation in data,analytics,and tech
SINGAPORE,Feb. 13,2025-- ShengShu Technology,a world pioneer in generative AI video,announces the API platform for its flagship video generation application,Vidu,marking a major advancement in scalabl
KUALA LUMPUR,Malaysia,Feb. 13,2025-- As a continuation of its globallyrecognised \'Time for\' campaign,Malaysia Airlines is proud to unveil \'Time for Premium Leisure\',a campaign that redefines Busi